Physician
Anesthesiology
Dr. Robert L. Kirkman, MD
|
|
Give Review
Robert Kirkman works in the field of Anesthesiology. He graduated from University of Virginia School of Medicine. Robert L. Kirkman, MD is a published doctor as well. He has 54 publications published. The latest was: Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation.
- CD8 T cells are sufficient to mediate allorecognition and allograft rejection.
- Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids.
- Spontaneous acceptance or rejection of orthotopic liver transplants in outbred and partially inbred miniature swine.
- Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.
- Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
- Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants.
- Insights into the mechanism of allograft acceptance in T-cell receptor (beta-chain) transgenic mice.
- Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts.
- Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1.
- Allorecognition in T-cell receptor (beta-chain) transgenic mice.
- Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.
- Inhibitory effect of cyclosporine on specific secretory IgA production against cholera toxin in small bowel transplantation.
- A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
- Immune function in transplanted small intestine. II: sIgA production in cholera toxin-primed rats.
- RO 23-6457 prolongs survival of vascularized allografts in rodents and primates.
- The role of a primate model of renal transplantation in the development of new monoclonal antibodies.
- Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation.
- Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody.
- Enhancement of immunosuppression by substitution of fish oil for olive oil as a vehicle for cyclosporine.
- Management of general surgical complications following cardiac transplantation.
- Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin-2 fusion protein.
- Early experience with anti-Tac in clinical renal transplantation.
- Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in mice.
- Cardiac allograft survival in mice treated with IL-2-PE40.
- Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys.
- In vivo anti-interleukin-2 receptor (anti-Tac) therapy is immunosuppressive, but not tolerogenic.
- Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.
- T cell activation antigens: therapeutic implications.
- Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
- Prolongation of primate renal allografts with anti-Tac monoclonal antibody.
- Inhibition of allograft rejection and organ-specific autoimmune disease by anti-interleukin-2 receptor (IL-2R)-targeted immunotherapy. The action of anti-IL-2R monoclo...
- Nutritional and metabolic aspects of total small bowel transplantation in inbred rats.
- Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.
- Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
- Anti-T12 monoclonal antibody therapy of acute renal allograft rejection.
- Long-term results of cyclosporine treatment in renal transplantation.
- Treatment with anti-interleukin-2 receptor monoclonal antibody.
- The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection.
- Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.
- Failure of cyclosporine to prevent small bowel allograft rejection in pigs.
- Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.
- Structural and functional evolution of jejunal allograft rejection in rats and the ameliorating effects of cyclosporine therapy.
- Conversion from cyclosporine to azathioprine in renal allograft recipients.
- Experience with cyclosporine and steroids in clinical renal transplantation.
- Small bowel transplantation.
- Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody.
- Monoclonal anti-T12 antibody as therapy for renal allograft rejection.
- Late mortality and morbidity in recipients of long-term renal allografts.
- Transplantation in miniature swine. VII. Evidence for cellular immune mechanisms in hyperacute rejection of renal alografts.
- Transplantation in miniature swine. VI. Factors influencing survival of renal allografts.
- Evidence for cellular immune mechanisms in hyperacute rejection of renal allografts in miniature swine.
- Transplantation in miniature swine. III: effects of MSLA and A-O blood group matching on skin allograft survival.
Schools
University of Virginia Main Campus
New England Deaconess Hospital
Naval Regional Med Center
Naval Regional Med Center Va
Doctors Specialties
- Anesthesiology
- Internal Medicine
Accepted Insurances
Education
-
Naval Medical Center -
Beth Israel Deaconess Medical Center -
University of Virginia School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629077623 |
| Last Name Of The Provider | KIRKMAN |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Keith N. Cohen, PHD |
|
|
Dr. Charles J. McInnis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin P. Maynard III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin Walecka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Steriti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Venkata Ravi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen Punzak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark C. Norris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jan P. Matejka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald Lambert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monique M. Marin-Santoni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael H. Esteghamati, MD |
|
|
Dr. Jared Barlow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur T. Dayton, MD
This Doctor is OpenDoctor Recommended.
|